secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001641172-25-022002
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical elects two new directors; two directors resign
------------------------------------------------------------

- Abhinav Jain and Tyler Lipschultz elected to Xtant Medical Board effective August 1, 2025.
- Robert McNamara and Lori Mitchell-Keller resigned as directors effective same date; no disagreement.
- Jain is an analyst at Nantahala Capital (49.1% owner) and serves on Aytu BioPharma and Talphera boards.
- Lipschultz brings 35+ years orthopaedics/spine experience, previously at Orthofix, SeaSpine, NuVasive.
- Appointments at Nantahala's request; Nantahala purchased 57M shares at $0.42 in April 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000164117225022002/0001641172-25-022002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000164117225022002/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer